Single User License
INR 101235
Site License
INR 202470
Corporate User License
INR 303705

Service Tax Additional

select a format
Price

Single User License
USD 1500
Site License
USD 3000
Corporate User License
USD 4500

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Asubio Pharma Co., Ltd.-Product Pipeline Review-2015

Asubio Pharma Co., Ltd.-Product Pipeline Review-2015


  Request for Sample Report

Executive Summary

Asubio Pharma Co., Ltd.-Product Pipeline Review-2015

Summary

Global Markets Direct's, 'Asubio Pharma Co., Ltd.-Product Pipeline Review-2015', provides an overview of the Asubio Pharma Co., Ltd.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Asubio Pharma Co., Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides brief overview of Asubio Pharma Co., Ltd. including business description, key information and facts, and its locations and subsidiaries

The report reviews current pipeline of Asubio Pharma Co., Ltd.'s human therapeutic division and enlists all their major and minor projects

The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones

Special feature on out-licensed and partnered product portfolio

The report summarizes all the dormant and discontinued pipeline projects

Latest company statement

Latest news and deals relating to the Asubio Pharma Co., Ltd.'s pipeline products

Reasons To Buy

Evaluate Asubio Pharma Co., Ltd.'s strategic position with total access to detailed information on its product pipeline

Assess the growth potential of Asubio Pharma Co., Ltd. in its therapy areas of focus

Identify new drug targets and therapeutic classes in the Asubio Pharma Co., Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas

Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps

Develop strategic initiatives by understanding the focus areas of Asubio Pharma Co., Ltd. and exploit collaboration and partnership opportunities

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Plan mergers and acquisitions effectively by identifying the most promising pipeline of Asubio Pharma Co., Ltd.

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Explore the dormant and discontinued projects of Asubio Pharma Co., Ltd. and identify potential opportunities in those areas

Avoid Intellectual Property Rights related issues

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

Asubio Pharma Co., Ltd. Snapshot 4

Asubio Pharma Co., Ltd. Overview 4

Key Information 4

Key Facts 4

Asubio Pharma Co., Ltd.-Research and Development Overview 5

Key Therapeutic Areas 5

Asubio Pharma Co., Ltd.-Pipeline Review 7

Pipeline Products by Stage of Development 7

Pipeline Products-Monotherapy 8

Asubio Pharma Co., Ltd.-Pipeline Products Glance 9

Asubio Pharma Co., Ltd.-Clinical Stage Pipeline Products 9

Phase II Products/Combination Treatment Modalities 9

Asubio Pharma Co., Ltd.-Early Stage Pipeline Products 10

Preclinical Products/Combination Treatment Modalities 10

Discovery Products/Combination Treatment Modalities 11

Asubio Pharma Co., Ltd.-Drug Profiles 12

SUN-13837 12

Product Description 12

Mechanism of Action 12

R&D Progress 12

ASB-14780 13

Product Description 13

Mechanism of Action 13

R&D Progress 13

SUN-11602 14

Product Description 14

Mechanism of Action 14

R&D Progress 14

Small Molecules for Undisclosed Indication 15

Product Description 15

Mechanism of Action 15

R&D Progress 15

Asubio Pharma Co., Ltd.-Pipeline Analysis 16

Asubio Pharma Co., Ltd.-Pipeline Products by Target 16

Asubio Pharma Co., Ltd.-Pipeline Products by Route of Administration 17

Asubio Pharma Co., Ltd.-Pipeline Products by Molecule Type 18

Asubio Pharma Co., Ltd.-Pipeline Products by Mechanism of Action 19

Asubio Pharma Co., Ltd.-Recent Pipeline Updates 20

Asubio Pharma Co., Ltd.-Dormant Projects 21

Asubio Pharma Co., Ltd.-Locations And Subsidiaries 22

Head Office 22

Other Locations & Subsidiaries 22

Appendix 23

Methodology 23

Coverage 23

Secondary Research 23

Primary Research 23

Expert Panel Validation 23

Contact Us 23

Disclaimer 24

List of Tables

Asubio Pharma Co., Ltd., Key Information 4

Asubio Pharma Co., Ltd., Key Facts 4

Asubio Pharma Co., Ltd.-Pipeline by Indication, 2015 6

Asubio Pharma Co., Ltd.-Pipeline by Stage of Development, 2015 7

Asubio Pharma Co., Ltd.-Monotherapy Products in Pipeline, 2015 8

Asubio Pharma Co., Ltd.-Phase II, 2015 9

Asubio Pharma Co., Ltd.-Preclinical, 2015 10

Asubio Pharma Co., Ltd.-Discovery, 2015 11

Asubio Pharma Co., Ltd.-Pipeline by Target, 2015 16

Asubio Pharma Co., Ltd.-Pipeline by Route of Administration, 2015 17

Asubio Pharma Co., Ltd.-Pipeline by Molecule Type, 2015 18

Asubio Pharma Co., Ltd.-Pipeline Products by Mechanism of Action, 2015 19

Asubio Pharma Co., Ltd.-Recent Pipeline Updates, 2015 20

Asubio Pharma Co., Ltd.-Dormant Developmental Projects,2015 21

Asubio Pharma Co., Ltd., Subsidiaries 22

List of Figures

Asubio Pharma Co., Ltd.-Pipeline by Top 10 Indication, 2015 6

Asubio Pharma Co., Ltd.-Pipeline by Stage of Development, 2015 7

Asubio Pharma Co., Ltd.-Monotherapy Products in Pipeline, 2015 8

Asubio Pharma Co., Ltd.-Pipeline by Top 10 Target, 2015 16

Asubio Pharma Co., Ltd.-Pipeline by Top 10 Molecule Type, 2015 18

Asubio Pharma Co., Ltd.-Pipeline Products by Top 10 Mechanism of Action, 2015 19

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Current R&D Portfolio of Asubio Pharma Co., Ltd.; Asubio Pharma Co., Ltd. - Key Therapeutics; Asubio Pharma Co., Ltd. - Pipeline Overview and Promising Molecules; Asubio Pharma Co., Ltd. - News; Asubio Pharma Co., Ltd. - Latest Updates; Asubio Pharma Co., Ltd. - Pipeline; Asubio Pharma Co., Ltd. - Discontinued/Dormant Projects


Related Products in vertical
Other reports by publisher
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com